Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001880253 | SCV002254518 | uncertain significance | Neuronal ceroid lipofuscinosis 7 | 2022-05-15 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with asparagine, which is neutral and polar, at codon 39 of the MFSD8 protein (p.Ile39Asn). This variant is present in population databases (rs140349255, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with MFSD8-related conditions. ClinVar contains an entry for this variant (Variation ID: 990258). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001278244 | SCV001465242 | uncertain significance | Late-infantile neuronal ceroid lipofuscinosis | 2020-06-19 | no assertion criteria provided | clinical testing |